1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Establishing a Center for the Advancement of SUD Pharmacotherapeutics (U54) is sponsored by National Institutes of Health (NIDA). Planning NOFO to establish a translational center for SUD pharmacotherapeutic development, training, and outreach.
Application snapshot: target deadline March 10, 2026; published funding information Approximately $3,000,000 for first year, one award; eligibility guidance Governments, nonprofits, educational institutions, tribal organizations.
Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Get alerted about grants like this
Save a search for “National Institutes of Health (NIDA)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) Agency: National Institutes of Health Assistance Listings: 93.
279 -- Drug Use and Addiction Research Programs Last Updated: December 22, 2025 View version history on Grants. gov The National Institute on Drug Abuse (NIDA) seeks to advance its mission by establishing a Center that educates and supports researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics.
The Center will also help advance the best concepts through initial experiments via technical and financial support. Previous NIDA-supported initiatives in early translational research have shown that drug addiction researchers are eager to acquire formal product development skills and access technical expertise and support.
Prospective applicants are encouraged to: develop plans for a product development curriculum to be taught to SUD researchers, outline outreach and networking initiatives to engage the research community and recruit researchers' concepts for development within the Center, and describe the infrastructure support that may be provided for initial experiments. style="margin-left:0px;">Applications are not being solicited at this time.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. Investigators with expertise in the areas of drug discovery and development and institutional capacities to support such a Center are encouraged to begin to consider applying for this NOFO.
Grant authorities that allow NIH to forecast this opportunity are as follows Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Part 75 and 2 CFR Part 200].
Public and Indian housing authorities City or township governments Special district governments Federally recognized Native American tribal governments For-profit organizations other than small businesses Other Native American tribal organizations Nonprofits non-higher education with 501(c)(3) Nonprofits non-higher education without 501(c)(3) Private institutions of higher education Independent school districts Public and state institutions of higher education Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.
S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U. S.)
Entities (Foreign Institutions). Grantor contact information No documents are currently available. Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity :
Based on current listing details, eligibility includes: Governments, nonprofits, educational institutions, tribal organizations. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Approximately $3,000,000 for first year, one award Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is March 10, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
The purpose of this Mentored Career Enhancement grant awards (K18) in Patient Centered Outcomes Research (PCOR) NOFO is to target established mid-career and senior investigators who are interested in developing new skills in comparative effectiveness research methodology and applying these methods to patient-centered outcome research (PCOR). Funding Opportunity Number: PA-22-051. Assistance Listing: 93.226. Funding Instrument: G. Category: HL.
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) is sponsored by National Institutes of Health. Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) is a forecasted funding opportunity on Grants.gov from National Institutes of Health. Fiscal Year: 2027. Assistance Listing Number(s): 93.279. <p style="margin-left:0px;">The National Institute on Drug Abuse (NIDA) seeks to advance its mission by establishing a Center that educates and supports researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics. The Center will also help advance the best concepts through initial experiments via technical and financial support. Previous NIDA-supported initiatives in early translational research have shown that drug addiction researchers are eager to acqui... Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information See Grants.gov forecast notice for estimated funding details.; eligibility guidance Eligible applicant types: [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object]. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) is sponsored by National Institutes of Health. This opportunity supports mission-aligned projects and measurable outcomes. Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information See Grants.gov forecast notice for estimated funding details.; eligibility guidance Eligible applicant types: [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [objec… Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.